What are the odds of getting a kidney stone in your lifetime?
Evidence quality 4.75/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 5/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 5/5
- D4 Uncertainty
- 4/5
- D5 Scope
- 5/5
- D6 Prose
- 5/5
- D7 Perception honesty
- 4/5
- D8 Caveat completeness
- 5/5
Lifetime probability · lifetime, US adult
1 in 11
9.0% lifetime chance
range 1 in 14 to 1 in 8.3
● your factors — click this risk ▾ to reveal
≈ As likely as
Perceived
Most adults have heard at least one vivid first-person account of passing a kidney stone, and the consensus cultural shorthand is "worst pain of my life". That framing makes the fear primarily about intensity, not frequency. People generally know kidney stones are common — nobody files them alongside shark attacks or lightning — but the anticipated pain dominates the emotional weighting. There is no large-scale survey quantifying perceived lifetime kidney stone probability as a standalone risk, so the kind here is intuition rather than poll.
Rough estimate: Most adults intuit kidney stones as fairly common — roughly 1 in 10 to 1 in 20 — which is approximately right
Source: editorial intuition, not polled
Actual
~1 in 11 US adults will have a symptomatic kidney stone in their lifetime
US adults, age-adjusted, both sexes combined
Show derivation
Uses the NHANES cross-sectional prevalence data analysed by Scales et al. (2012, European Urology) as the primary anchor: 10.6% self-reported lifetime prevalence in men and 7.1% in women during 2007–2010, up from 6.3% and 4.1% respectively in the 1988–1994 wave. Sex-weighted average for the US adult population is approximately 8.8%, rounded to 0.09 (~1 in 11). This is prevalence of at least one symptomatic episode, not incidence per year. The secular trend is upward — Stamatelou et al. (2003) documented a rising prevalence between 1976 and 1994, and the Scales update confirmed the trend continued through 2010. Rule et al. (2009, Mayo Clinic/Olmsted County) found incidence increased particularly in women, narrowing the historical sex gap. Uncertainty range 0.07–0.12 reflects the sex-weighted band and ongoing secular increase. The number is symptomatic stones only; asymptomatic stones detected incidentally on imaging are excluded from the NHANES self-report methodology.
Caveats: Kidney stones are almost never fatal — annual US mortality is in the low hundred…
Kidney stones are almost never fatal — annual US mortality is in the low hundreds, making the death rate negligible. The fear is about pain and recurrence, not survival. The 8.8% headline is symptomatic stones only; asymptomatic stones found incidentally on CT or ultrasound are far more common but clinically irrelevant unless they grow or migrate. The secular trend is upward and likely driven by rising obesity, dietary sodium, and climate warming; the true 2026 prevalence may already exceed 10%. Roughly 80% of stones are calcium oxalate; the remainder (uric acid, strite, cystine) have different risk profiles and recurrence patterns. Recurrence is the dominant clinical concern: about 50% of first-time stone formers will have another episode within 5–7 years without preventive intervention.
Regional breakdown
The headline figure averages across very different populations. Here’s how the probability varies by geography or context:
| Region / context | Lifetime probability | Notes |
|---|---|---|
| US men | 1 in 9.4 |
NHANES 2007–2010; ~1 in 9 |
| US women | 1 in 14 |
NHANES 2007–2010; ~1 in 14; gap narrowing over time |
| US Southeast ('stone belt') | 1 in 8.3 |
Higher rates in hot, humid climates; dehydration and dietary factors |
| Prior stone formers (recurrence within 5–7 years) | 1 in 2.0 |
~50% recurrence rate without preventive intervention |
Risks at similar odds
Other risks with roughly the same likelihood — useful for calibration.
End-stage kidney disease
What are the lifetime odds of developing end-stage kidney disease requiring dialysis or transplant?
Bipolar disorder
What are the odds of developing bipolar disorder at some point in your lifetime?
Recently viewed on this device
Stored locally — clear anytime.
Pick challenger
About 1 in 11 US adults will experience a symptomatic kidney stone at some point, according to NHANES data analysed by Scales et al. (2012): 10.6% lifetime prevalence in men, 7.1% in women. That number has been climbing steadily; it was 3.8% in the late 1970s and 5.2% in the early 1990s, and the NIDDK rounds the current male figure to 11%. The trend is real, driven by rising obesity, higher dietary sodium, and possibly climate warming. Kidney stones sit in roughly the same order of magnitude as a lifetime type 2 diabetes death risk, about 10,000x above a lightning strike, and meaningfully below lifetime cancer mortality.
The unusual feature of kidney stones as a fear is that the fear is roughly proportionate to the experience. People are not wildly overestimating or underestimating the frequency; they know it is common. What drives the outsized dread is the reported pain intensity, routinely described as comparable to or exceeding childbirth in patient surveys. The gap between “how afraid people are” and “how likely it is” is small. The gap between “how afraid people are” and “how dangerous it is” is large: kidney stones are almost never fatal. Annual US stone-related deaths number in the low hundreds across a population of 330 million.
Where the headline does not apply evenly: men run about 1.5 times the risk of women, though that gap has narrowed considerably since the 1970s when it was closer to 3:1. Geography matters — the US Southeast “stone belt” shows prevalence roughly 30% above the national average, likely from heat-driven dehydration. And recurrence is the real clinical burden: roughly half of first-time stone formers will have a second episode within five to seven years without dietary or pharmacological intervention. A single lifetime stone is a coin-flip on whether it becomes a recurring condition.
Related tidbits
Kidney stones affect roughly 11% of people over a lifetime. Appendicitis hits about 8%. Combined, nearly 1 in 5 adults will experience one of these acute abdominal emergencies. Neither appears in anyone's financial planning.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
-
[1] European Urology (Scales et al.) — Prevalence of Kidney Stones in the United States
Prevalence of Kidney Stones in the United States- Statistic
Overall prevalence of kidney stones was 8.8% (10.6% in men, 7.1% in women) during 2007–2010, up from 5.2% in 1988–1994- Excerpt
“"The prevalence of stone disease in the United States has increased from 5.2% in NHANES III (1988–1994) to 8.8% in NHANES 2007–2010. Men had a higher prevalence of stones than women (10.6% vs 7.1%)." ”
- Source data from
- 2012-05-17
- Accessed
- 2026-04-18 · archived copy
- Calculation
- Scales et al. analysed NHANES 2007–2010 (n = 12,110) and found 8.8% self-reported lifetime prevalence of kidney stones in US adults. This is the direct anchor for the headline ~1 in 11 figure. Sex-specific rates (10.6% M, 7.1% F) inform the personal_factor_multipliers. The study also documented the secular trend from 5.2% (1988–1994) to 8.8% (2007–2010), confirming that the true current figure may be higher still.
- Independence
- NHANES is a nationally representative cross-sectional survey run by NCHS/CDC. This is the primary US epidemiological dataset for kidney stone prevalence and is independent of the clinic-based Mayo/Olmsted County cohort (Rule et al.).
-
[2] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH) — Definition & Facts for Kidney Stones
Definition & Facts for Kidney Stones- Statistic
About 11 percent of men and 6 percent of women in the United States have kidney stones at least once during their lifetime- Excerpt
“"About 11 percent of men and 6 percent of women in the United States have kidney stones at least once during their lifetime." ”
- Source data from
- 2024-03-01
- Accessed
- 2026-04-18 · archived copy
- Calculation
- NIDDK's fact sheet rounds the Scales et al. NHANES figures to 11% (men) and 6% (women). The sex-combined midpoint is ~8.5%, consistent with the 8.8% from the primary study. Used as the authoritative government framing of the same underlying NHANES data.
- Independence
- NIDDK republishes NHANES-derived prevalence data; same upstream dataset as the Scales et al. study. Included as the institutional government citation rather than as an independent verification.
-
[3] Kidney International (Rule et al.) — Kidney Stones in a Population-Based Study (Rochester Epidemiology Project)
Kidney Stones in a Population-Based Study (Rochester Epidemiology Project)- Statistic
Incidence of kidney stones increased from 1970 to 2000, with a particularly marked increase among women- Excerpt
“"The incidence of kidney stones increased overall during the study period (1970–2000) particularly among women, in whom the age-adjusted incidence rate nearly doubled." ”
- Source data from
- 2009-06-01
- Accessed
- 2026-04-18 · archived copy
- Calculation
- Rule et al. used the Rochester Epidemiology Project (Olmsted County, MN) to track first-episode kidney stone incidence from 1970 to 2000. The study confirmed rising incidence and a narrowing of the male-to-female ratio from ~3:1 to ~1.3:1 in younger cohorts. This clinic-based incidence data provides an independent cross-check on the NHANES prevalence trend.
- Independence
- The Rochester Epidemiology Project is a population-based medical records linkage system in Olmsted County, MN — methodologically independent of the NHANES cross-sectional survey used by Scales et al.
-
[4] Kidney International (Stamatelou et al.) — Time Trends in Reported Prevalence of Kidney Stones in the United States: 1976–1994
Time Trends in Reported Prevalence of Kidney Stones in the United States: 1976–1994- Statistic
Lifetime prevalence of kidney stones increased from 3.8% in 1976–1980 to 5.2% in 1988–1994- Excerpt
“"The lifetime prevalence of kidney stone disease increased 37% between NHANES II (1976–1980; 3.8%) and NHANES III (1988–1994; 5.2%)." ”
- Source data from
- 2003-05-01
- Accessed
- 2026-04-18 · archived copy
- Calculation
- Stamatelou et al. documented the secular trend from NHANES II through NHANES III, establishing the trajectory that Scales et al. later extended to 8.8% in the 2007–2010 wave. The 37% relative increase across 15 years is consistent with the continued rise through the 2000s.
- Independence
- Same upstream NHANES data programme as the Scales et al. analysis, but covering earlier waves (1976–1994 vs 2007–2010). Included for the secular trend, not as an independent prevalence estimate.